Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.350
+0.030 (2.27%)
At close: Apr 2, 2026, 4:00 PM EDT
1.355
+0.005 (0.37%)
After-hours: Apr 2, 2026, 4:30 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $83.58 million as of April 2, 2026. Its market cap has decreased by -15.74% in one year.
Market Cap
83.58M
Enterprise Value
-78.25M
1-Year Change
-15.74%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $83.58M, a decrease of -88.67%. That is a compound annual growth rate of -31.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 83.58M | 11.49% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gossamer Bio | 86.84M |
| Anixa Biosciences | 85.50M |
| Kazia Therapeutics | 83.87M |
| PolyPid | 83.78M |
| Rani Therapeutics Holdings | 83.75M |
| Filana Therapeutics | 83.57M |
| aTyr Pharma | 83.04M |
| NeurAxis | 81.11M |